MedPath

Lubiprostone

Lubiprostone Capsules

Approved
Approval ID

81f9c9de-f89d-4ab0-a8ca-18d3691e42f9

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 24, 2023

Manufacturers
FDA

Zydus Lifesciences Limited

DUNS: 918596198

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lubiprostone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70771-1764
Application NumberANDA214131
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lubiprostone
Product Specifications
Route of AdministrationORAL
Effective DateMarch 24, 2023
FDA Product Classification

INGREDIENTS (9)

1,4-SORBITANInactive
Code: AV0YTZ4E6J
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
LUBIPROSTONEActive
Quantity: 24 ug in 1 1
Code: 7662KG2R6K
Classification: ACTIB
MEDIUM-CHAIN TRIGLYCERIDESInactive
Code: C9H2L21V7U
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT

Lubiprostone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70771-1763
Application NumberANDA214131
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lubiprostone
Product Specifications
Route of AdministrationORAL
Effective DateMarch 24, 2023
FDA Product Classification

INGREDIENTS (11)

LUBIPROSTONEActive
Quantity: 8 ug in 1 1
Code: 7662KG2R6K
Classification: ACTIB
1,4-SORBITANInactive
Code: AV0YTZ4E6J
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
MEDIUM-CHAIN TRIGLYCERIDESInactive
Code: C9H2L21V7U
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lubiprostone - FDA Drug Approval Details